Role of artificial intelligence in Crohn's disease intestinal strictures and fibrosis

Yi Fei Chen1, Liu Liu1, Bin Lyu1

  • 1Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, Zhejiang Province, China.

PubMed

Insights

Artificial intelligence (AI) aids in detecting intestinal fibrosis and stricture in Crohn's disease (CD). AI offers accurate and fast identification and prediction, improving upon manual methods for this common complication.

Area of Science:

  • Gastroenterology and Artificial Intelligence
  • Medical Imaging and Diagnostics
  • Inflammatory Bowel Disease Research

Background:

  • Crohn's disease (CD) is a chronic gastrointestinal inflammatory disorder.
  • Intestinal fibrosis and stricture are frequent, recurring complications of CD.
  • Manual assessment of fibrosis/stricture can be subjective and time-consuming.

Purpose of the Study:

  • To review the application of artificial intelligence (AI) in diagnosing intestinal fibrosis and stricture in Crohn's disease.
  • To categorize AI diagnostic approaches based on detection modalities.
  • To evaluate AI's efficacy in identifying and predicting these CD complications.

Main Methods:

  • Systematic review of studies published in the last decade on AI for CD intestinal fibrosis/stricture.
  • Categorization of AI applications by detection method: endoscopy, imaging, and biomarkers.
  • Analysis of AI's performance in accuracy and speed of diagnosis.

Main Results:

  • AI techniques demonstrate significant potential in detecting intestinal fibrosis and stricture in CD patients.
  • AI applications span various diagnostic modalities, including endoscopy and medical imaging.
  • Studies show AI facilitates more accurate and expedited identification and prediction of fibrotic complications.

Conclusions:

  • Artificial intelligence offers a promising tool for improving the diagnosis of intestinal fibrosis and stricture in Crohn's disease.
  • AI-driven approaches can overcome limitations of manual examination, enhancing diagnostic efficiency and accuracy.
  • Further integration of AI in clinical practice may lead to better patient management and outcomes in CD.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
133
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
420